1. Home
  2. RDIB vs TIL Comparison

RDIB vs TIL Comparison

Compare RDIB & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDIB
  • TIL
  • Stock Information
  • Founded
  • RDIB 1937
  • TIL 2018
  • Country
  • RDIB United States
  • TIL United States
  • Employees
  • RDIB N/A
  • TIL N/A
  • Industry
  • RDIB Movies/Entertainment
  • TIL Biotechnology: Pharmaceutical Preparations
  • Sector
  • RDIB Consumer Discretionary
  • TIL Health Care
  • Exchange
  • RDIB Nasdaq
  • TIL Nasdaq
  • Market Cap
  • RDIB 140.2M
  • TIL 171.7M
  • IPO Year
  • RDIB N/A
  • TIL 2021
  • Fundamental
  • Price
  • RDIB $6.37
  • TIL $20.59
  • Analyst Decision
  • RDIB
  • TIL Strong Buy
  • Analyst Count
  • RDIB 0
  • TIL 4
  • Target Price
  • RDIB N/A
  • TIL $114.00
  • AVG Volume (30 Days)
  • RDIB 3.4K
  • TIL 105.4K
  • Earning Date
  • RDIB 03-28-2025
  • TIL 03-20-2025
  • Dividend Yield
  • RDIB N/A
  • TIL N/A
  • EPS Growth
  • RDIB N/A
  • TIL N/A
  • EPS
  • RDIB N/A
  • TIL N/A
  • Revenue
  • RDIB $197,270,000.00
  • TIL N/A
  • Revenue This Year
  • RDIB N/A
  • TIL N/A
  • Revenue Next Year
  • RDIB $14.40
  • TIL $2.64
  • P/E Ratio
  • RDIB N/A
  • TIL N/A
  • Revenue Growth
  • RDIB N/A
  • TIL N/A
  • 52 Week Low
  • RDIB $5.78
  • TIL $9.62
  • 52 Week High
  • RDIB $21.34
  • TIL $92.00
  • Technical
  • Relative Strength Index (RSI)
  • RDIB 44.73
  • TIL 44.30
  • Support Level
  • RDIB $6.05
  • TIL $19.03
  • Resistance Level
  • RDIB $6.77
  • TIL $26.80
  • Average True Range (ATR)
  • RDIB 0.15
  • TIL 2.20
  • MACD
  • RDIB -0.01
  • TIL 0.22
  • Stochastic Oscillator
  • RDIB 73.10
  • TIL 20.08

About RDIB Reading International Inc Class B

Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial, and live theater assets.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: